Breast Carcinoma with Oncotype DX Recurrence Score Lower Than 18: Rate of Distant Metastases in a Large Series with Clinical Follow-Up

BACKGROUNDS: A 21-gene expression assay (Oncotype DX™ Recurrence Score (“RS”)) that utilizes RT-PCR is used clinically in early-stage estrogen receptor-positive, HER2-negative breast carcinoma (ER+/HER2− BC) to determine both prognosis with tamoxifen therapy and the utility of adding adjuvant chemot...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer
Asıl Yazarlar: Wen, Hannah Y, Krystel-Whittemore, Melissa, Patil, Sujata, Pareja, Fresia, Bowser, Zenica L, Dickler, Maura N., Norton, Larry, Morrow, Monica, Hudis, Clifford A., Brogi, Edi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161549/
https://ncbi.nlm.nih.gov/pubmed/27526056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30271
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller